Brief Pain Reprocessing Therapy: An Optimized Integrative Exposure Intervention for Veterans With Chronic Low Back Pain
Sponsor: University of Michigan
Trial Details
| Condition | Chronic Lower Back Pain (CLBP) |
| Intervention | Brief Pain Reprocessing Therapy (BPRT) |
| Phase | NA |
| Status | Recruiting |
| Participants | 47 |
| Est. Completion | 1 Jan 2027 |
| Last Updated | 22 May 2026 |
Primary Outcome
Acceptability of and satisfaction with treatment base on the mean scores on the Treatment Evaluation Inventory (TEI-SF) assessed at T5 (approximately day 35); Feasibility will be accessed by participant adherence; Feasibility will be accessed by feedback from the Qualitative Interviews; Safety will be assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS 29) pain intensity; Safety will be assessed by the PROMIS Depression scale; Safety will be assessed by the PROMIS Anxiety scale; Safety will be assessed by the Patient Global Impression of Change (PGIC); Safety assessed by the number of Adverse events and Serious adverse events T6 (Day 60) - T9 (Day 210)
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Low back pain that has lasted greater than 6 months, with pain on at least half of these days * Must provide verification of being an Armed Service Veteran. * Able to read, write and speak English * Internet access and audio-conferencing capability (e.g., Zoom meetings by phone or computer) in the home Exclusion Criteria: * Self-reported evidence of a separate medical condition (e.g., rheumatoid arthritis), acute injury in the past 12 months (e.g., self-reported spinal fracture), self-reported loss of bowel or bladder control in the past year (which may indicate presence of cauda equina syndrome), or evidence of presence of a metastasizing cancer requiring treatment * Pending surgical procedures or interventional therapies (e.g., spinal injections) within the next 12 months * Confirmed/suspected pregnancy * Evidence of other conditions that may preclude participants from understanding or being able to participate in study procedure (e.g., schizoaffective disorder, suspected or diagnosed dementia) * Currently receiving cognitive-behavioral therapy or other psychological therapies for pain * Open litigation in the past 1 year, as assessed in preliminary study screening. * Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service